Verdecchia, P., G. Reboldi, F. Angeli, R. Gattobigio, C. Borgioni, L. Filippucci, F. Poeta, and C. Porcellati. 2004. Prognositc value of lipoprotein fractions in essential hypertension. Blood Pressure 13(5):295–303.

Verschuren, W. M., D. R. Jacobs, B. P. Bloemberg, D. Kromhout, A. Menotti, C. Aravanis, H. Blackburn, R. Buzina, A. S. Dontas, F. Fidanza, M. J. Karvonen, S. Nedeljkovic, A. Nissinen, and H. Toshima. 1995. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: Twenty-five-year follow-up of the seven countries study. Journal of the American Medical Association 274(2):131–136.

Virella, G., and M. F. Lopes-Virella. 2008. Atherogenesis and the humoral immune response to modified lipoproteins. Atherosclerosis 200(2):239–246.

Vokurka, E. A., A. Herwadkar, N. A. Thacker, R. T. Ramsden, and A. Jackson. 2002. Using Bayesian tissue classification to improve the accuracy of vestibular schwannoma volume and growth measurement. American Journal of Neuroradiology 23(3):459-467.

Wahl, R. L., H. Jacene, Y. Kasamon, and M. A. Lodge. 2009. From RECIST to PERCIST: Evolving considerations for PET Response Criteria in Solid Tumors. Journal of Nuclear Medicine 50(Suppl 1):122S–150S.

Wallace, T. W., S. M. Abdullah, M. H. Drazner, S. R. Das, A. Khera, D. K. McGuire, F. Wians, M. S. Sabatine, D. A. Morrow, and J. A. de Lemos. 2006. Prevalence and determinants of troponin T elevation in the general population. Circulation 113(16):1958–1965.

Walter, M. 2009. Interrelationships among HDL metabolism, aging, and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 29(9):1244–1250.

Wang, T. J., P. Gona, M. G. Larson, G. H. Tofler, D. Levy, C. Newton-Chen, P. F. Jacque, N. Rifai, J. Selhub, S. J. Robins, E. J. Benjamin, R. D’Agostino, and S. V. Ramachamdan. 2006. Multiple biomarkers for the prediction of first major cardiovascular events and death. New England Journal of Medicine 355(25):2631–2639.

Watanabe, Y., T. Ito, and M. Shiomi. 1985. The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits: An animal model for familial hypercholesterolemia. Atherosclerosis 56:71–79.

Weber, W. A. 2009. Assessing tumor response to therapy. Journal of Nuclear Medicine 50(Suppl 1):1S–10S.

Welsh, P., C. J. Packard, and N. Sattar. 2008. Novel antecedent plasma biomarkers of cardiovascular disease: Improved evaluation methods and comparator benchmarks raise the bar. Current Opinion in Lipidology 19(6):563–571.

Weverling-Rijnsburger, A. W. E., G. J. Blauw, A. M. Lagaay, D. L. Knook, A. E. Meinders, and R. G. J. Westendorp. 1997. Total cholesterol and risk of mortality in the oldest old. Lancet 350(9085):1119–1123.

Whicher, J. T. 1998. BCR/IFCC reference material for plasma proteins (CRM 470). Community Bureau of Reference. International Federation of Clinical Chemistry. Clinical Biochemistry 31(6):459–465.

Whitton, C. M., D. Sands, A. R. Hubbard, and P. J. Gaffney. 2000. A collaborative study to establish the 2nd International Standard for Fibrinogen, Plasma. Thrombosis and Haemostasis 84(2):258–262.

Williams, P. T., H. R. Superko, W. L. Haskell, E. L. Alderman, P. J. Blanche, L. G. Holl, and R. M. Krauss. 2003. Smallest LDL particles are most strongly related to coronary disease progression in men. Arteriosclerosis, Thrombosis, and Vascular Biology 23(2):314–321.

Wood, L. G., D. A. Fitzgerald, P. G. Gibson, D. M. Cooper, C. E. Collins, and M. L. Garg. 2001. Oxidative stress in cystic fibrosis: Dietary and metabolic factors. Journal of the American College of Nutrition 20(2):157–165.

Wu, A. H. B., and A. S. Jaffe. 2008. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. American Heart Journal 155(2):208–214.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement